Status:
UNKNOWN
ACTIVPROSEIN : Professional Activity After Breast Cancer
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Breast Cancer Female
Return to Work
Eligibility:
FEMALE
18-60 years
Brief Summary
Breast cancer is, in term of incidence, the first cancer among women in France and worldwide. This incidence is increasing, particularly among young women during their professional activity. Those ob...
Detailed Description
Patients being took care in Grenoble University Hospital, including Voiron site, from 2015 to 2019, for a localized breast cancer, will be identified be Cristal Link software. A questionary, includin...
Eligibility Criteria
Inclusion
- Patient between 18 and 60 years old
- Histologically proven localized breast cancer, of any subtype
- Cared in Grenoble University Hospital between 2015 and 2019
- Working at the time of diagnosis
Exclusion
- Retired at the end of adjuvant therapy
- Deprived of liberty, under juridical protection, not able to give consent
- Psychiatric conditions or addictive behavior interfering with questionary filling
Key Trial Info
Start Date :
September 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 13 2025
Estimated Enrollment :
578 Patients enrolled
Trial Details
Trial ID
NCT06025604
Start Date
September 14 2023
End Date
September 13 2025
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, France, 38043